You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Doxorubicin and docetaxel

Showing 1 - 25 of 3,122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022

Triple Negative Breast Cancer Trial in Zhengzhou (Docetaxel +doxorubicin+ cyclophosphamide, Docetaxel +Cisplatin)

Recruiting
  • Triple Negative Breast Cancer
  • Docetaxel +doxorubicin+ cyclophosphamide
  • Docetaxel +Cisplatin
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 18, 2022

Hand-Foot Syndrome, Breast Cancer Trial in Stuttgart (Ice Plant Intensive Cream plus Standard Care, Standard Care)

Not yet recruiting
  • Hand-Foot Syndrome
  • Breast Cancer
  • Ice Plant Intensive Cream plus Standard Care
  • Standard Care
  • Stuttgart, Germany
    Robert-Bosch-Hospital
Feb 22, 2023

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Breast Cancer, Chemotherapeutic Toxicity Trial in Hanzhou (Liposomal doxorubicin + Cyclophosphamide vs Docetaxel +

Recruiting
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Liposomal doxorubicin + Cyclophosphamide vs Docetaxel + Cyclophosphamide
  • Hanzhou, Zhejing, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Apr 7, 2022

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

Breast Cancer Trial in Guangzhou (standard adjuvant chemo plus moxifloxacin, standard adjuvant chemo plus )

Recruiting
  • Breast Cancer
  • standard adjuvant chemotherapy plus moxifloxacin
  • standard adjuvant chemotherapy plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2021

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +

Completed
  • Breast Cancer
  • Breast Neoplasms
  • Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
  • Fayetteville, Arkansas
  • +1 more
Jan 26, 2023

Breast Cancer Trial in India (Carboplatin, Cyclophosphamide, Docetaxel)

Completed
  • Breast Cancer
  • Hyderabad, Andhra Pradesh, India
  • +5 more
Aug 5, 2021

Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,

Recruiting
  • Breast Cancer
  • carboplatin, thiotepa, and cyclophosphamide
  • chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
  • Amsterdam, Netherlands
    NKI-AVL
Mar 21, 2022

Locally Advanced Breast Cancer Trial in New York (Docetaxel, Carboplatin, Trastuzumab)

Terminated
  • Locally Advanced Breast Cancer
  • New York, New York
  • +2 more
Oct 18, 2021

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +5 more
Jan 26, 2023

Breast Cancer Trial in Pittsburgh (Bevacizumab, Doxorubicin, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • Pittsburgh, Pennsylvania
    NSABP Foundation, Inc.
Apr 9, 2021

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 26, 2023

Breast Tumors Trial in San Sebastián de los Reyes (Docetaxel, 5-fluorouracil, Doxorubicin)

Completed
Has Results
  • Breast Neoplasms
  • San Sebastián de los Reyes, Madrid, Spain
    Spanish Breast Cancer Research Group
Nov 10, 2020

Triple Negative Breast Cancer (TNBC) Trial in Changchun (Camrelizumab, Doxorubicin, Cyclophosphamide)

Recruiting
  • Triple Negative Breast Cancer (TNBC)
  • Changchun, Jilin, China
    Aiping Shi
Oct 11, 2021

Breast Cancer Trial (TAC, NX)

Completed
  • Breast Cancer
  • (no location specified)
Feb 2, 2021

Breast Cancer Trial in Bloomington, New York (Nivolumab 360mg, Paclitaxel 80mg/m^2, Doxorubicin 60mg/m^2)

Completed
Has Results
  • Breast Cancer
  • Nivolumab 360mg
  • +6 more
  • Bloomington, Indiana
  • +1 more
Feb 2, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Breast Cancer, Hormone-receptor Positive Breast Cancer Trial in Guangzhou (Pyrotinib, Epirubicin, Doxorubicin Hydrochloride

Recruiting
  • Breast Cancer
  • Hormone-receptor Positive Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Apr 29, 2021